Related references
Note: Only part of the references are listed.Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2
Jessica Cusato et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)
Pharmacogenomics research and clinical implementation in Brazil
Fernanda Rodrigues-Soares et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2019)
Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug
Lili Chan et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2018)
Tenofovir disoproxil fumarate co-administered with lopinavir/ritonavir is strongly associated with tubular damage and chronic kidney disease
Daisuke Mizushima et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2018)
Polymorphisms of tenofovir disoproxil fumarate transporters and risk of kidney tubular dysfunction in HIV-positive patients: genetics of tenofovir transporters
Mohammed I. Danjuma et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2018)
Renal Drug Transporters and Drug Interactions
Anton Ivanyuk et al.
CLINICAL PHARMACOKINETICS (2017)
Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines
A. Calcagno et al.
PHARMACOGENOMICS JOURNAL (2016)
A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection
Sirirat Likanonsakul et al.
PLOS ONE (2016)
Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic Study
Takeshi Nishijima et al.
PLOS ONE (2015)
Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Gregory M. Lucas et al.
CLINICAL INFECTIOUS DISEASES (2014)
The role of drug transporters in the kidney: lessons from tenofovir
Darren M. Moss et al.
FRONTIERS IN PHARMACOLOGY (2014)
Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B
N. Gara et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Renal Toxicity Associated With Antiretroviral Therapy
Leonardo Calza
HIV CLINICAL TRIALS (2012)
Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence
Andrew M. Hall et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Genetic Variants of ABCC10, a Novel Tenofovir Transporter, Are Associated With Kidney Tubular Dysfunction
Sudeep P. Pushpakom et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy
Frederic-Antoine Dauchy et al.
KIDNEY INTERNATIONAL (2011)
Disorders of the Renal Proximal Tubule
Arend Bokenkamp et al.
NEPHRON PHYSIOLOGY (2011)
The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters
Olena Kis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Pharmacogenetics of tenofovir treatment
Sonia Rodriguez-Novoa et al.
PHARMACOGENOMICS (2009)
Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy
Hassane Izzedine et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Share Paper
